CHIEF OPERATING OFFICER · CVRx, Inc. · Common Stock
Open-market sale
$3K reported value · 4.1% of prior position
Disclosed 1 business day after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 51 | Binkowski BrentCHIEF OPERATING OFFICER | Open-market purchase | BUY | $76K 26.2K sh | Aug 13, 2026 traded Aug 13, 2026 | |
| 21 | Adamson Philip B.Chief Medical Officer | Grant or award · 10b5-1 plan | A | — 41.0K sh | Mar 16, 2026 traded Feb 27, 2026 | |
| 15 | Adamson Philip B.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $9,973 1,262 sh | Mar 16, 2026 traded Mar 2, 2026 | |
| 9 | Adamson Philip B.Chief Medical Officer | Grant or award · 10b5-1 plan | A | — 62.0K sh | Mar 16, 2026 traded Feb 27, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $3,338
Binkowski Brent filed this Form 4 reporting a open-market sale of CVRX on Aug 12, 2026. It became public on Aug 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.